Alpha-fetoprotein and ultrasonography tests are provided for men and women aged 40 years or older with chronic HBV or hepatitis C virus (HCV) infection, liver cirrhosis, or chronic liver disease of any cause [30], [31]. This evidence concerns the gene AFP and hepatitis C virus infection.